Description
Coartem 80/480 (Artemether/Lumefantrine) Tablets is the original, globally trusted artemisinin-based combination therapy (ACT) from Novartis for the treatment of acute, uncomplicated malaria in adults and children weighing 35 kg and above.
Each tablet contains Artemether 80 mg + Lumefantrine 480 mg — a powerful dual-action combination that works in two coordinated stages:
-
Artemether rapidly clears the initial parasite load from the bloodstream, relieving fever, chills, and body aches.
-
Lumefantrine remains in the system longer, eliminating residual parasites to prevent relapse and treatment failure.
Key Features:
-
Complete 6-tablet course — a strict 6-dose regimen spread over 3 days
-
Effective against Plasmodium falciparum malaria, including chloroquine-resistant strains
-
WHO-recommended first-line antimalarial therapy
-
Manufactured by Novartis — the original developer of the artemether/lumefantrine combination
-
For adults and children weighing 35 kg and above
